<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119390">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01966770</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-44</org_study_id>
    <nct_id>NCT01966770</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses</brief_title>
  <official_title>Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this fitting study is to evaluate the clinical performance of different hydrogel
      and silicone hydrogel contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Subjective Assessment: Change in Comfort and lens fit.</measure>
    <time_frame>Change from baseline over 30 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjective Assessment: Comfort and Lens fit using questionnaire with Visual Analog Scale (0-100)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Objective Practitioner Measurements: Change in Ocular response</measure>
    <time_frame>Change from baseline at end of pair three</time_frame>
    <safety_issue>No</safety_issue>
    <description>Objective Practitioner Measurements: Ocular response by Biomicroscopy Scale 0-4</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>ocufilD/ocufilD, ocufilD/enfilA, ocufilD/comfilA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Day one - randomized lens pair 1 (ocufilcon D / ocufilcon D) , pair 2 (ocufilcon D / enfilcon A) or pair 3 (ocufilcon D / comfilcon A)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>metafilA/metafilA, metafilA/comfilA, omafilA/comfilA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Day two - randomized lens pair 1 (metafilcon A / metafilcon A), pair 2 (metafilcon A / comfilcon A) or pair 3 (omafilcon A / comfilcon A)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ocufilD/ocufilD, ocufilD/enfilA, ocufilD/comfilA</intervention_name>
    <description>Day one - randomized lens pair 1 (ocufilcon D / ocufilcon D) , pair 2 (ocufilcon D / enfilcon A) or pair 3 (ocufilcon D / comfilcon A)</description>
    <arm_group_label>ocufilD/ocufilD, ocufilD/enfilA, ocufilD/comfilA</arm_group_label>
    <other_name>(ocufilcon D) Biomedics 55</other_name>
    <other_name>(enfilcon A) Avaira</other_name>
    <other_name>(comfilcon A) Biofinity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>metafilA/metafilA, metafilA/comfilA, omafilA/comfilA</intervention_name>
    <description>Day two - randomized lens pair 1 (metafilcon A / metafilcon A), pair 2 (metafilcon A / comfilcon A) or pair 3 (omafilcon A / comfilcon A)</description>
    <arm_group_label>metafilA/metafilA, metafilA/comfilA, omafilA/comfilA</arm_group_label>
    <other_name>(metafilcon A) Frequency 55</other_name>
    <other_name>(comfilcon A) Biofinity</other_name>
    <other_name>(omafilcon A) Proclear</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          -  Is between 18 and 40 years of age (inclusive)

          -  Has had a self-reported visual exam in the last two years

          -  Is an adapted soft (contact lens) cl wearer

          -  Has a cl spherical prescription between -1.00 and -6.00 (inclusive)

          -  Has a spectacle cylinder up to 0.75D in each eye

          -  Is correctable to a visual acuity of 20/25 or better in both eyes

          -  Has clear corneas and no active ocular disease

          -  Has read, understood and signed the information consent letter

          -  Is willing to comply with the wear schedule

          -  Is willing to comply with the visit schedule

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          -  Has never worn contact lenses before

          -  Currently wears rigid gas permeable contact lenses

          -  Has a history of not achieving comfortable CL wear (5 days per week; &gt; 8 hours/day)

          -  Has a CL prescription outside the range of -1.00 to -6.00D

          -  Has a spectacle cylinder â‰¥ 1.00D of cylinder in either eye

          -  Has best corrected spectacle distance vision worse than 20/25 in either eye

          -  Has any systemic or topical medications that will affect ocular health

          -  Has any ocular pathology or severe insufficiency of lacrimal secretion

          -  Has persistent, clinically significant corneal or conjunctival staining

          -  Has active neovascularization or any central corneal scars

          -  Is aphakic

          -  Is presbyopic

          -  Has undergone corneal refractive surgery

          -  Is participating in any other type of eye related conical or research study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meng Lin, OD PhD FAAO</last_name>
    <role>Principal Investigator</role>
    <affiliation>CRC-UC Berkeley</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Berkeley Clinical Research Center (UCB-CRC)</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94720-2020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 3, 2014</lastchanged_date>
  <firstreceived_date>October 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
